These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3196055)

  • 1. Glucagon for hypoglycaemia in infants small for gestational age.
    Carter PE; Lloyd DJ; Duffty P
    Arch Dis Child; 1988 Oct; 63(10):1264-6. PubMed ID: 3196055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal blood glucose concentrations: metabolic effects of intravenous glucagon and intragastric medium chain triglyceride.
    Hawdon JM; Aynsley-Green A; Ward Platt MP
    Arch Dis Child; 1993 Mar; 68(3 Spec No):255-61. PubMed ID: 8466259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of glucagon induces severe hyponatremia and thrombocytopenia in a premature neonate.
    Belik J; Musey J; Trussell RA
    Pediatrics; 2001 Mar; 107(3):595-7. PubMed ID: 11230607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with intravenous glucagon infusions as a treatment for resistant neonatal hypoglycemia.
    Miralles RE; Lodha A; Perlman M; Moore AM
    Arch Pediatr Adolesc Med; 2002 Oct; 156(10):999-1004. PubMed ID: 12361445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia.
    Mehta A; Wootton R; Cheng KN; Penfold P; Halliday D; Stacey TE
    Arch Dis Child; 1987 Sep; 62(9):924-30. PubMed ID: 3314727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic effects of glucagon infusion in normoglycaemic and hypoglycaemic small-for-gestational-age infants. I. Changes in blood glucose, blood lactate and plasma free fatty acids.
    Schultz K; Mestyán J; Soltész G; Horváth M
    Acta Paediatr Acad Sci Hung; 1976; 17(3):237-44. PubMed ID: 1027323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous hydrocortisone administration on glucose homeostasis in small for gestational age infants.
    Sann L; Ruitton A; Mathieu M; Lasne Y
    Acta Paediatr Scand; 1979 Jan; (1):113-8. PubMed ID: 758722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and metabolic response to hypoglycaemia in small for gestational age infants.
    Hawdon JM; Weddell A; Aynsley-Green A; Ward Platt MP
    Arch Dis Child; 1993 Mar; 68(3 Spec No):269-73. PubMed ID: 8466261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neontal hypoglycaemia in infants of insulin-dependent diabetic mothers.
    Martin FI; Dahlenburg GW; Russell J; Jeffery P
    Arch Dis Child; 1975 Jun; 50(6):472-6. PubMed ID: 1170817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral glucose in neonates with an increased risk of neonatal hypoglycaemia halves the number of neonates receiving intravenous glucose].
    Austie FMC; van Unen HJ; Smit-Wu MN; Bekhof J
    Ned Tijdschr Geneeskd; 2021 Mar; 165():. PubMed ID: 33720562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
    Rachman J; Barrow BA; Levy JC; Turner RC
    Diabetologia; 1997 Feb; 40(2):205-11. PubMed ID: 9049482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal hypoglycaemia--the controversy regarding definition.
    Koh TH; Eyre JA; Aynsley-Green A
    Arch Dis Child; 1988 Nov; 63(11):1386-8. PubMed ID: 3202648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma chromium levels in small-for-gestational-age newborn infants.
    Yurdakök M; Ozer D; Erdem G; Temizer A
    Turk J Pediatr; 1993; 35(1):37-40. PubMed ID: 8236515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prehospital treatment of severe hypoglycaemia: a comparison of intramuscular glucagon and intravenous glucose.
    Carstens S; Sprehn M
    Prehosp Disaster Med; 1998; 13(2-4):44-50. PubMed ID: 10346406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to glucagon in small-for-dates hypoglycaemic and non-hypoglycaemic newborn infants.
    Le Dune MA
    Arch Dis Child; 1972 Oct; 47(255):754-9. PubMed ID: 5086509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of genetically engineered glucagon on glucose recovery after hypoglycaemia in man.
    Hvidberg A; Jørgensen S; Hilsted J
    Br J Clin Pharmacol; 1992 Dec; 34(6):547-50. PubMed ID: 1493086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia?
    Taylor JR; Sherratt HS; Davies DM
    Eur J Clin Pharmacol; 1978 Nov; 14(2):125-7. PubMed ID: 363433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.